张华, 陈旭义, 杨波, 张明华, 王仁杰. 肝细胞肝癌患者血清microRNA-224水平变化及其临床诊断意义的研究[J]. 中国肿瘤临床, 2014, 41(9): 576-579. DOI: 10.3969/j.issn.1000-8179.20140061
引用本文: 张华, 陈旭义, 杨波, 张明华, 王仁杰. 肝细胞肝癌患者血清microRNA-224水平变化及其临床诊断意义的研究[J]. 中国肿瘤临床, 2014, 41(9): 576-579. DOI: 10.3969/j.issn.1000-8179.20140061
ZHANG Hua, CHEN Xuyi, YANG Bo, ZHANG Minghua, WANG Renjie. Research on the serum level of microRNA-224 in hepatocellular carcinoma patients and its clinical diagnostic significance[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2014, 41(9): 576-579. DOI: 10.3969/j.issn.1000-8179.20140061
Citation: ZHANG Hua, CHEN Xuyi, YANG Bo, ZHANG Minghua, WANG Renjie. Research on the serum level of microRNA-224 in hepatocellular carcinoma patients and its clinical diagnostic significance[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2014, 41(9): 576-579. DOI: 10.3969/j.issn.1000-8179.20140061

肝细胞肝癌患者血清microRNA-224水平变化及其临床诊断意义的研究

Research on the serum level of microRNA-224 in hepatocellular carcinoma patients and its clinical diagnostic significance

  • 摘要:
      目的  探讨肝细胞肝癌患者血清microRNA-224水平变化及其临床诊断意义。
      方法  采用实时荧光定量PCR检测42例肝细胞肝癌患者(hepatocellular carcinoma,HCC)、36例肝硬化患者(LC)、55例慢性乙型肝炎患者(CHB)以及40例健康体检者(NC)血清miR-224表达量。计算miR-224相对表达量。通过分析受试者工作特征曲线(ROC)判断miR-224表达水平在肝癌诊断中的灵敏度和特异度。
      结果  HCC组患者血清miR-224相对表达量均高于CHB组、LC组和NC组,差异有统计学差异(P < 0.05或P < 0.01)。HCC患者血清miR-224相对表达量与甲胎蛋白(AFP)呈正相关(P < 0.05)。与肿瘤大小、TNM分期、肿瘤分化程度以及淋巴结转移无相关性(P>0.05)。ROC分析确定了最佳的miR-224相对表达量的临界值为3.47,灵敏度被确定为82.2%,特异性为92.8%,曲线下面积(AUC)为0.935。
      结论  肝细胞肝癌患者血清中miR-224特异性高表达,将使其可能成为一种新的血清学指标用于肝细胞肝癌的诊断。

     

    Abstract:
      Objective  To investigate the serum level of miR-224 in hepatocellular carcinoma (HCC) patients and its clinical diagnostic significance.
      Methods  The serum level of miR-224 was detected by real-time quantitative PCR. This study included 42 cases of patients with HCC, 36 patients with liver cirrhosis (LC), 55 patients with chronic hepatitis B (CHB), and 40 healthy persons (NC). The relative expressions of miR-224 were calculated. The receiver operating characteristic (ROC) curves were analyzed to determine the sensitivity and specificity of miR-224 expression levels in HCC diagnosis.
      Results  Result shows that the relative miR-224 expression was higher in the serum of HCC patients than that in the CHB, LC, and NC groups. The difference was statistically significant (P < 0.05 or P < 0.01). The relative miR-224 expression in the serum of HCC patients and alpha fetoprotein (AFP) were positively correlated (P < 0.05). By comparison, the tumor size, TNM stage, tumor differentiation, and lymph node metastasis were not correlated with mirR-224 expression (P>0.05). ROC analysis shows that the best critical value of the relative expression levels of miR-224 was 3.47, with sensitivity of 82.2%, specificity of 92.8%, and area under the curve of 0.935.
      Conclusion  The serum level of miR-224 in HCC patients has high specificity, and miR-224 has great potential to become a new serological marker for the diagnosis of HCC.

     

/

返回文章
返回